HOME \ Outreach \ Outreach articles \

Clinical study of a trial on VLP vaccine for bluetongue virus serotypes 1 & 1+4 in sheep


July 1st, 2009

Perez de Diego AC., del Carmen P., Carvajal J. and Sanchez-Vizcaino JM..

Revista Complutense de Ciencias Veterinarias publish this article


Bluetongue Virus disease is an infectous disease submitted to a sanitary control composed by several measures of prevention, and one of these measures is the vaccination of the sensible species. In the development of vaccines opposite to this disease, a new trend is the production of polyvalent vaccines by VLP`s technology (virus like particles). This work has had as aim to value by clinical survey, 2 VLP vaccines, for serotypes 1 and 1+4. The results confirm the
lack of fever, clinical signs and pathologic injuries in vaccinated animals opposite to control animals, which indicates that these new vaccines protect for the appearance of clinical signs



See document in PDF
Clinical study of a trial on VLP vaccine for bluetongue virus serotypes 1 & 1+4 in sheep





Revista Complutense de Ciencias Veterinarias

TITLE: Clinical study of a trial on VLP vaccine for bluetongue virus serotypes 1 & 1+4 in sheep


TYPE: Article


AUTHORS: Perez de Diego AC., del Carmen P., Carvajal J. and Sanchez-Vizcaino JM..


JOURNAL: Revista Complutense de Ciencias Veterinarias


LANGUAJE: Spanish


ISBN: 1988-2688


NUMERATION: 3 (2):69-78


DATE: July 1st, 2009


PUBLISHING COMPANY: Universidad Complutense



CITE THIS PUBLICATION:

Perez de Diego AC., del Carmen P., Carvajal J. and Sanchez-Vizcaino JM.. Clinical study of a trial on VLP vaccine for bluetongue virus serotypes 1 & 1+4 in sheep.. Revista Complutense de Ciencias Veterinarias. 3 (2):69-78. Universidad Complutense. ISBN: 1988-2688. 2009.